Pfizer says its COVID pill reduces risk of hospitalisation, death by 89%

Pfizer’s anti-COVID pill PAXLOVID reduced the risk of hospitalisation or death for any cause by around 89 percent compared to placebo in patients treated within 5 days of onset of symptoms.

Related Keywords

,Albert Bourla ,Pfizer ,Drug Administration ,Protease Inhibition ,Emergency Use Authorisation ,Pfizer Covid 19 Pill ,Pfizer Anti Covid Pill ,Paxlovid ,Pfizer Paxlovid ,Paxlovid Covid 19 Pill ,Paxlovid Pill ,Axlovid Effects ,Axlovid Side Effects ,Pfizer Ceo ,Pfizer Chairman ,Us Food And Drug Administration ,S Fda ,